DS
PLSE icon

David Shaw’s Pulse Biosciences PLSE Stock Holding History

David Shaw’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.27M Buy
81,818
+68,092
+496% +$1.61M ﹤0.01% 3090
2026
Q1 		$296K Buy
+13,726
New +$253K ﹤0.01% 4077
2022
Q3 		– Sell
-31,827
Closed -$49K – 5448
2022
Q2 		$49K Sell
31,827
-69,189
-68% -$174K ﹤0.01% 4845
2022
Q1 		$491K Buy
+101,016
New +$827K ﹤0.01% 4379
2021
Q3 		– Sell
-17,528
Closed -$287K – 5161
2021
Q2 		$287K Buy
+17,528
New +$334K ﹤0.01% 4304
2021
Q1 		– Sell
-12,391
Closed -$296K – 4397
2020
Q4 		$296K Buy
+12,391
New +$197K ﹤0.01% 3605

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

David Shaw's PLSE Position: Q2 2026 in Review

David Shaw increased its Pulse Biosciences (PLSE) stake by 496% in Q2 2026, buying an estimated $1.61M and bringing the position to 81,818 shares worth $2.27M. The position accounts for ﹤0.01% of the portfolio, ranked #3090.

David Shaw first reported a position in PLSE in Q4 2020 and has held it in 6 quarters since. 106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • David Shaw held 81,818 shares of Pulse Biosciences worth $2.27M as of Q2 2026.
  • David Shaw bought 68,092 Pulse Biosciences shares in Q2 2026, an estimated $1.61M.
  • Pulse Biosciences made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #3090 holding.
  • David Shaw first reported a position in Pulse Biosciences in Q4 2020 and has held it in 6 quarters since.
  • 106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.